Sales 2024 * | 6TCr 6.61TCr 6.12TCr 5,51700Cr | Sales 2025 * | 6.38TCr 7.02TCr 6.51TCr 5,86600Cr | Capitalization | 18TCr 20TCr 19TCr 16,90900Cr |
---|---|---|---|---|---|
Net income 2024 * | 1.35TCr 1.48TCr 1.37TCr 1,23800Cr | Net income 2025 * | 1.49TCr 1.64TCr 1.52TCr 1,36700Cr | EV / Sales 2024 * | 3.3 x |
Net Debt 2024 * | 1.42TCr 1.57TCr 1.45TCr 1,31000Cr | Net Debt 2025 * | 818.32Cr 901.12Cr 835.18Cr 75TCr | EV / Sales 2025 * | 3.01 x |
P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
12.1
x | Employees | 1,03,605 |
Yield 2024 * |
4.27% | Yield 2025 * |
4.41% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 01/03/01 | |
Severin Schwan
CHM | Chairman | 57 | 01/08/01 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03/15/03 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01/96/01 |
1st Jan change | Capi. | |
---|---|---|
+29.98% | 68TCr | |
+31.84% | 59TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+16.51% | 24TCr | |
+9.46% | 21TCr | |
+7.09% | 17TCr | |
-1.22% | 16TCr |